We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+2.83%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$7.76B
AUM Growth
+$499M
Cap. Flow
+$366M
Cap. Flow %
4.71%
Top 10 Hldgs %
15.72%
Holding
1,667
New
74
Increased
571
Reduced
929
Closed
86

Top Buys

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$48.8M
2
DOC icon
Healthpeak Properties
DOC
+$16.2M
3
CLX icon
Clorox
CLX
+$16.1M
4
BF.B icon
Brown-Forman Class B
BF.B
+$14.4M
5
HRL icon
Hormel Foods
HRL
+$14.3M

Sector Composition

Rank Sector Weight
1 Healthcare 16.62%
2 Technology 13.27%
3 Financials 13.22%
4 Consumer Staples 11.59%
5 Industrials 8.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIT icon
1301
Applied Industrial Technologies
AIT
$12.6B
$249K ﹤0.01%
5,515
-498
-8% -$22.3K
ARDX icon
1302
Ardelyx
ARDX
$1.25B
$249K ﹤0.01%
28,575
+262
+0.9% +$2.14K
FCNCA icon
1303
First Citizens BancShares
FCNCA
$24.1B
$249K ﹤0.01%
963
-57
-6% -$14.3K
EXLS icon
1304
EXL Service
EXLS
$4.1B
$248K ﹤0.01%
23,655
-520
-2% -$5.27K
SSD icon
1305
Simpson Manufacturing
SSD
$7.68B
$248K ﹤0.01%
6,198
-93
-1% -$3.58K
CLH icon
1306
Clean Harbors
CLH
$16.2B
$247K ﹤0.01%
4,742
-602
-11% -$30.1K
LPLA icon
1307
LPL Financial
LPLA
$26.2B
$247K ﹤0.01%
10,950
-128
-1% -$3.21K
HMHC
1308
DELISTED
Houghton Mifflin Harcourt Company
HMHC
$246K ﹤0.01%
15,755
-1,591
-9% -$28.9K
AKBA icon
1309
Akebia Therapeutics
AKBA
$338M
$244K ﹤0.01%
32,665
+831
+3% +$7.25K
CGEN icon
1310
Compugen
CGEN
$229M
$244K ﹤0.01%
37,652
+300
+0.8% +$2K
ROL icon
1311
Rollins
ROL
$20.9B
$243K ﹤0.01%
18,702
-2,633
-12% -$32.3K
SPLK
1312
DELISTED
Splunk Inc
SPLK
$243K ﹤0.01%
+4,485
New +$237K
NATI
1313
DELISTED
National Instruments Corp
NATI
$243K ﹤0.01%
8,860
-1,255
-12% -$35K
MGEE icon
1314
MGE Energy Inc
MGEE
$3.13B
$242K ﹤0.01%
4,278
-13,949
-77% -$722K
SFR
1315
DELISTED
Starwood Waypoint Homes
SFR
$242K ﹤0.01%
+7,955
New +$212K
EQY
1316
DELISTED
Equity One
EQY
$242K ﹤0.01%
7,529
-10,881
-59% -$319K
AAT
1317
American Assets Trust
AAT
$1.49B
$241K ﹤0.01%
5,668
+215
+4% +$8.63K
CCOI icon
1318
Cogent Communications
CCOI
$648M
$241K ﹤0.01%
6,007
-573
-9% -$22.5K
B
1319
DELISTED
Barnes Group Inc.
B
$241K ﹤0.01%
7,279
-588
-7% -$20K
AXE
1320
DELISTED
Anixter International Inc
AXE
$241K ﹤0.01%
4,528
+113
+3% +$6.48K
MSTR icon
1321
Strategy Inc
MSTR
$36.3B
$240K ﹤0.01%
13,700
+190
+1% +$3.5K
ICUI icon
1322
ICU Medical
ICUI
$3.93B
$239K ﹤0.01%
2,124
+62
+3% +$6.43K
CBM
1323
DELISTED
Cambrex Corporation
CBM
$239K ﹤0.01%
4,615
+54
+1% +$2.58K
HL icon
1324
Hecla Mining
HL
$10.5B
$238K ﹤0.01%
46,692
+1,357
+3% +$5.49K
WDFC icon
1325
WD-40
WDFC
$3.18B
$237K ﹤0.01%
2,021
-70
-3% -$7.59K

Similar funds

ProShare Advisors's Q2 2016 Portfolio in Review

As of Q2 2016, ProShare Advisors held 1,667 positions worth $7.76B, up 6.9% from $7.26B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

ProShare Advisors deployed $366M of net new capital in Q2 2016, opening 74 new positions and adding to 571 existing holdings. Its largest new stake was S&P Global: 454,450 shares worth $48.7M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Apple, an estimated $10.8M trimmed.

  • ProShare Advisors's largest Q2 2016 buy was S&P Global: 454,450 shares worth $48.7M.
  • ProShare Advisors added most to Healthpeak Properties in Q2 2016, an estimated $16.2M increase.
  • ProShare Advisors's biggest Q2 2016 reduction was Apple, cutting an estimated $10.8M.
  • ProShare Advisors fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $36.9M.
  • ProShare Advisors's ten largest holdings make up 16% of its $7.76B portfolio in Q2 2016.
  • ProShare Advisors opened 74 new positions and closed 86 in Q2 2016.
  • ProShare Advisors's portfolio value rose 6.9% quarter-over-quarter to $7.76B.

Based on ProShare Advisors's 13F filing for Q2 2016, filed 12 Aug 2016.